Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica N McAlpine

Showing results (61-70 of 186) with videos related to

Pageof 19
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2020
Interlaboratory Concordance of ProMisE Molecular Classification of Endometrial Carcinoma Based on Endometrial Biopsy SpecimensAnna Plotkin, Boris Kuzeljevic, Vanessa De Villa, et al.
JAMA Network Open|February 9, 2022
Outcomes From Opportunistic Salpingectomy for Ovarian Cancer PreventionGillian E Hanley, Celeste Leigh Pearce, Aline Talhouk, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|February 13, 2014
The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shiftClare J Reade, Ruaidhrí M McVey, Alicia A Tone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
Molecular Subtype Not Immune Response Drives Outcomes in Endometrial CarcinomaAline Talhouk, Heather Derocher, Pascal Schmidt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2024
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasionAmy Jamieson, Marcel Grube, Samuel Leung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasionAmy Jamieson, Marcel Grube, Samuel Leung, et al.
Histopathology|June 19, 2024
The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profileMona Alafraidi, Lynn Hoang, Brooke E Howitt, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 9, 2023
Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive AnalysisParamdeep Kaur, Khaye Rufin, Sarah J Finlayson, et al.
Gynecologic Oncology|December 31, 2024
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer managementAndrea Neilson, Amy Jamieson, Derek Chiu, et al.
Obstetrics and Gynecology|January 9, 2015
Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategyJanice S Kwon, Jessica N McAlpine, Gillian E Hanley, et al.
Pageof 19

Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2020
Interlaboratory Concordance of ProMisE Molecular Classification of Endometrial Carcinoma Based on Endometrial Biopsy SpecimensAnna Plotkin, Boris Kuzeljevic, Vanessa De Villa, et al.
JAMA Network Open|February 9, 2022
Outcomes From Opportunistic Salpingectomy for Ovarian Cancer PreventionGillian E Hanley, Celeste Leigh Pearce, Aline Talhouk, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|February 13, 2014
The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shiftClare J Reade, Ruaidhrí M McVey, Alicia A Tone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
Molecular Subtype Not Immune Response Drives Outcomes in Endometrial CarcinomaAline Talhouk, Heather Derocher, Pascal Schmidt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2024
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasionAmy Jamieson, Marcel Grube, Samuel Leung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasionAmy Jamieson, Marcel Grube, Samuel Leung, et al.
Histopathology|June 19, 2024
The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profileMona Alafraidi, Lynn Hoang, Brooke E Howitt, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 9, 2023
Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive AnalysisParamdeep Kaur, Khaye Rufin, Sarah J Finlayson, et al.
Gynecologic Oncology|December 31, 2024
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer managementAndrea Neilson, Amy Jamieson, Derek Chiu, et al.
Obstetrics and Gynecology|January 9, 2015
Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategyJanice S Kwon, Jessica N McAlpine, Gillian E Hanley, et al.
Pageof 19